WallStreetZenWallStreetZen

NASDAQ: SUPN
Supernus Pharmaceuticals Inc Stock Ownership - Who owns Supernus Pharmaceuticals?

OverviewForecastEarningsDividendOwnership

Insider buying vs selling

Have Supernus Pharmaceuticals Inc insiders been buying or selling?
Buy
Sell
NameRoleDateSharesPriceValue
Jack A. KhattarPresident CEO2024-09-0310,045$34.90
$350.57kSell
Padmanabh P. BhattSr. VP of IP CSO2024-08-20572$29.57
$16.91kSell
Padmanabh P. BhattSr. VP of IP CSO2024-03-2114,491$25.30
$366.62kBuy
Padmanabh P. BhattSr. VP of IP CSO2024-03-2114,491$35.31
$511.68kSell
Padmanabh P. BhattSr. VP of IP CSO2024-03-20400$35.31
$14.12kSell
Padmanabh P. BhattSr. VP of IP CSO2024-03-20400$25.30
$10.12kBuy
Padmanabh P. BhattSr. VP of IP CSO2024-03-1912,364$25.30
$312.81kBuy
Padmanabh P. BhattSr. VP of IP CSO2024-03-1912,364$35.31
$436.57kSell
Padmanabh P. BhattSr. VP of IP CSO2024-03-1326,250$34.10
$895.13kSell
Padmanabh P. BhattSr. VP of IP CSO2024-03-1326,250$23.99
$629.74kBuy

1 of 4

SUPN insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when SUPN insiders and whales buy or sell their stock.

SUPN Shareholders

What type of owners hold Supernus Pharmaceuticals Inc stock?
Institutional
Insider
Retail
NameHoldSharesValueType
Peter J. Barris21.52%11,859,518$402.16MInsider
Scott D. Sandell21.34%11,757,336$398.69MInsider
Forest Baskett21.32%11,746,274$398.32MInsider
Charles W. Newhall Iii19.52%10,758,339$364.82MInsider
Blackrock Inc18.86%10,392,636$352.41MInstitution
Vanguard Group Inc11.14%6,137,541$208.12MInstitution
Armistice Capital LLC9.57%5,272,000$178.77MInstitution
Krishna Kittu Kolluri6.97%3,841,172$130.25MInsider
New Enterprise Associates 11 LP6.93%3,820,625$129.56MInsider
Nea Partners 11 LP6.93%3,820,625$129.56MInsider

1 of 3

SUPN vs Pharmaceutical Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
SUPN45.89%54.11%Net SellingNet Selling
AMPH49.81%50.19%Net BuyingNet Selling
DVAX72.67%27.33%Net Selling
HROW27.02%72.98%Net Buying
TLRY9.71%2.11%Net BuyingNet Buying
View Top Pharmaceutical Stocks

Supernus Pharmaceuticals Stock Ownership FAQ

Who owns Supernus Pharmaceuticals?

Supernus Pharmaceuticals (NASDAQ: SUPN) is owned by 105.90% institutional shareholders, 124.89% Supernus Pharmaceuticals insiders, and 0.00% retail investors. Peter J. Barris is the largest individual Supernus Pharmaceuticals shareholder, owning 11.86M shares representing 21.52% of the company. Peter J. Barris's Supernus Pharmaceuticals shares are currently valued at $397.18M.

If you're new to stock investing, here's how to buy Supernus Pharmaceuticals stock.
©2024 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.